Association between green tea intake and coronary artery disease in a chinese population

Circulation Journal

Volumn 74, Issue 2, 2010, Pages 294-300

  Wang, Qi Ming ^a   Gong, Qing Yue ^b   Yan, Jian Jun ^a   Jun Zhu, ^a   Tang, Jian Jin ^a   Wang, Ming Wei ^a   Yang, Zhi Jian ^a   Wang, Lian Sheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Arteriography; Coronary artery disease; Green tea

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DOSE RESPONSE; DRINKING; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK REDUCTION; TEA;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CAMELLIA SINENSIS; CASE-CONTROL STUDIES; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TEA;

EID: 75749085412     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0543     Document Type: Article

References (35)

1. Graham HN. Green tea composition, consumption, and polyphenols chemistry. Prev Med 1992; 21: 334 - 350.
2. McKay DL, Blumberg JB. The role of tea in human health: An update. J Am Coll Nutr 2002; 21: 1 - 13.
3. Rao GH, White JC. Coronary artery disease: An overview of risk factors. Indian Heart J 1993; 45: 145 - 153.
4. Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T, et al. Effects of green tea intake on the development of coronary artery disease. Circ J 2004; 68: 665 - 670.
5. Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 2000; 10: 401 - 408.
6. Hirano R, Momiyama Y, Takahashi R, Taniguchi H, Kondo K, Nakamura H, et al. Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol 2002; 90: 1150 - 1153.
7. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Arch Intern Med 2003; 163: 1448 -1453.
8. Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003; 14: 326 - 332.
9. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J Nutr 2003; 133: 3275 - 3284.
10. Inami S, Takano M, Yamamoto M, Murakami D, Tajika K, Yodogawa K, et al. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Int Heart J 2007; 48: 725 - 732.
11. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med 2004; 164: 1534 - 1540.
12. Antonello M, Montemurro D, Bolognesi M, Di Pascoli M, Piva A, Grego F, et al. Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 2007; 20: 1321 - 1328.
13. Cheng HC, Chan CM, Tsay HS, Liang HJ, Liang YC, Liu DZ. Improving effects of epigallocatechin-3-gallate on hemorheological abnormalities of aging guinea pigs. Circ J 2007; 71: 597 - 603.
14. Jin YR, Im JH, Park ES, Cho MR, Han XH, Lee JJ, et al. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. J Cardiovasc Pharmacol 2008; 51: 45 - 54.
15. Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 1999; 96: 229 - 237.
16. Jochmann N, Lorenz M, Krosigk A, Martus P, Böhm V, Baumann G, et al. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 2008; 99: 863 - 868.
17. Lorenz M, Wessler S, Follmann E, Michaelis W, Düsterhöft T, Baumann G, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH- kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vaso-relaxation. J Biol Chem 2004; 279: 6190 - 6195.
18. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: S5 - S40.
19. Karadag B, Kucur M, Isman FK, Hacibekiroglu M, Vural VA. Serum chitotriosidase activity in patients with coronary artery disease. Circ J 2008; 72: 71 - 75.
20. Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 2005; 116: 972 - 983.
21. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 2001; 131: 27 - 32.
22. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JC. Tea flavonoids may protect against atherosclerosis: The Rotterdam Study. Arch Intern Med 1999; 159: 2170 - 2174.
23. Debette S, Courbon D, Leone N, Gariépy J, Tzourio C, Dartigues JF, et al. Tea consumption is inversely associated with carotid plaques in women. Arterioscler Thromb Vasc Biol 2008; 28: 353 - 359.
24. Miyauchi K, Takaya N, Hirose T, Ikeda F, Kawamori R, Ohishi H, et al. Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): Evaluation by magnetic resonance imaging. Circ J 2009; 73: 111 - 115.
25. Bursill CA, Abbey M, Roach PD. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 2007; 193: 86 - 93.
26. Yokozawa T, Nakagawa T, Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 2002; 50: 3549 - 3552.
27. Henricksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoproteins. Arteriosclerosis 1983; 3: 149 - 159.
28. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84: 2995 - 2998.
29. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983; 3: 215 - 222.
30. Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009; 73: 595 - 601.
31. Hakim IA, Harris RB, Weisgerber UM. Tea intake and squamous cell carcinoma of the skin: Influence of type of tea beverages. Cancer Epidemiol Biomarks Prev 2000; 9: 727 - 731.
32. Sullivan JM, Vander Zwaag R, Lemp GF, Hughes JP, Maddock V, Kroetz FW, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108: 358 - 363.
33. Wu AH, Arakawa K, Stanczyk FZ, Van Den Berg D, Koh WP, Yu MC. Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis 2005; 26: 976 - 980.
34. King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA 2008; 300: 2859 - 2866.
35. Xu W, Zhao Y, Guo L, Guo Y, Gao W. Job stress and coronary heart disease: A case-control study using a Chinese population. J Occup Health 2009; 51: 107 - 113.